About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Safety & Prevention Outcomes Study | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT01894087

Safety & Prevention Outcomes Study

Unintentional poisoning is a developing public health problem in the U.S. Unintentional poisoning (or "overdose") deaths increased 157% among adults between 1999 and 2008. There were \~700,000 emergen...

Lead sponsor: University of Michigan•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Michigan

Collaborators

Centers for Disease Control and Prevention

Age

18 - 60 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•patients 18-60 presenting to the ED for medical care
•ability to provide informed consent
•Additional criteria for intervention: past extramedical opioid use

Exclusion Criteria

•patients who do not understand English
•prisoners
•patients classified by medical staff as a "Level 1" trauma (e.g., in need of immediate lifesaving procedures)
•patients deemed unable to provide informed consent
•patients treated in the ED for suicide attempt or sexual assault

Related studies

Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder

NCT03745339 · Opioid-Related Disorders, Drug Addiction

RECRUITINGPhase 2

Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder

NCT05336188 · Opioid-Related Disorders, Mobile Applications, and more

Enrolling By InvitationNA

Alliances to Disseminate Addiction Prevention and Treatment (ADAPT)

NCT04499079 · Substance-Related Disorders, Recidivism, and more

Active Not RecruitingEARLY Phase 1

Tau PET Imaging in Opioid Use Disorder

NCT05651516 · Opioid-Related Disorders

Active Not RecruitingNA

Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder

NCT03950492 · Opioid-Related Disorders

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 19, 2018Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment204

Start dateApr 2013

Last updatedJan 19, 2018

Condition

Drug Overdose Opioid-Related Disorders

Locations shown

University of Michigan Health System Emergency Department

Ann Arbor, Michigan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 19, 2018Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions